PP
HCAT icon

PDT Partners’s Health Catalyst HCAT Stock Holding History

PDT Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-64,982
Closed -$630K – 744
2022
Q3 		$630K Buy
64,982
+16,752
+35% +$222K 0.1% 362
2022
Q2 		$699K Buy
+48,230
New +$822K 0.06% 513
2021
Q4 		– Sell
-10,533
Closed -$527K – 932
2021
Q3 		$527K Buy
10,533
+472
+5% +$25.7K 0.04% 465
2021
Q2 		$558K Buy
10,061
+4,704
+88% +$251K 0.04% 495
2021
Q1 		$251K Sell
5,357
-13,301
-71% -$644K 0.02% 655
2020
Q4 		$812K Buy
18,658
+51
+0.3% +$1.88K 0.05% 364
2020
Q3 		$681K Buy
+18,607
New +$632K 0.05% 377

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PDT Partners's HCAT Position: Q4 2022 in Review

PDT Partners sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 64,982 shares — an estimated $630K sold.

PDT Partners first reported a position in HCAT in Q3 2020 and held it in 7 quarters. The position peaked at $812K in Q4 2020. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • PDT Partners reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 64,982 Health Catalyst shares in Q4 2022, an estimated $630K.
  • PDT Partners first reported a position in Health Catalyst in Q3 2020 and held it in 7 quarters.
  • PDT Partners's Health Catalyst position peaked at $812K in Q4 2020.
  • 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.